STOCK TITAN

Quest Diagnostics Incorporated - $DGX STOCK NEWS

Welcome to our dedicated page for Quest Diagnostics Incorporated news (Ticker: $DGX), a resource for investors and traders seeking the latest updates and insights on Quest Diagnostics Incorporated stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Quest Diagnostics Incorporated's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Quest Diagnostics Incorporated's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
covid-19
-
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.61%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.3%
Tags
covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.21%
Tags
covid-19
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.83%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.06%
Tags
covid-19
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
none
Quest Diagnostics Incorporated

NYSE:DGX

DGX Rankings

DGX Stock Data

15.64B
109.71M
0.43%
91.73%
2.29%
Medical Laboratories
Health Care and Social Assistance
Link
United States of America
SECAUCUS

About DGX

quest diagnostics (nyse: dgx) empowers people to take action to improve health outcomes. derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. quest annually serves one in three adult americans and half the physicians and hospitals in the united states, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. the company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (ap) services, & interpretive consultation through its medical & scientific staff of about 900 m.d.s & ph.d.s. the company reported 2014 revenues of $7.4 billion. quest diagnostics offers the most extensive clinical testing network in the u.s., with laborator